• Toshinori Hasegawa, Kazunori Shintai, Takenori Kato, and Hiroshi Iizuka.
• Department of Neurosurgery, Gamma Knife Center, Komaki City Hospital, Komaki, Japan. Electronic address: h-toshi@komakihp.gr.jp.
• World Neurosurg. 2015 Jun 1;83(6):1173-9.

ObjectiveThe aim of this study was to confirm the efficacy and safety of stereotactic radiosurgery as the initial treatment for patients with nonfunctioning pituitary adenomas (NFPAs) and to decide the optimum dose to achieve long-term tumor control as well as preservation of pituitary endocrine function.MethodsThe study was a single-center retrospective analysis of 16 patients with primary NFPAs that were treated with gamma knife surgery (GKS). Fifteen of 16 NFPAs were growing to the suprasellar region and slightly compressing or very close to the optic apparatus. Initial GKS was selected to avoid visual disturbance caused by further tumor growth that would require surgical resection under general anesthesia. The median tumor volume was 2.0 cm(3), and the median tumor margin dose was 15 Gy.ResultsThe median clinical follow-up period was 98 months. The last follow-up images demonstrated tumor regression in 15 patients and stable tumor in 1. No patient developed tumor progression. One patient who had pituitary apoplexy before treatment required hormone replacements 2 years after GKS. The other patients did not experience pituitary insufficiency requiring hormone-replacement therapy during the clinical follow-up period. No patient developed cranial nerve injury or radiation-induced neoplasm.ConclusionsGKS is a safe and effective treatment option in patients with primary NFPAs, especially for patients with advanced age or comorbidity. Attention should be paid to late adverse radiation effects such as hypopituitarism, optic neuropathy, and radiation-induced neoplasms. However, stereotactic radiosurgery with a conformal treatment plan sparing the normal pituitary gland will contribute to avoidance of such complications as well as achievement of long-term tumor control.Copyright © 2015 Elsevier Inc. All rights reserved.

28 keywords...

hide…